Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
Ich bin Prof. Annkristin Heine - Krebszentrum CIO Bonn | Facebook
Bjørn Heine Strand - NIPH
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
Medicine®
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | SpringerLink
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
CIO Bonn - Lymphomzentrum
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
BG-flow, a new flow cytometry tool for G-quadruplex quantification in fixed cells | BMC Biology | Full Text
Auszeichnung für herausragende Krebsforscher - Centrum für Integrierte Onkologie
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation
Team | IMMEI
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
Implementing combinatorial immunotherapeutic regimens against cancer
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
G-quadruplexes: a promising target for cancer therapy | Molecular Cancer | Full Text
Immunotherapy as an advance in cancer medicine - Innovations Report
Pacritinib protects dendritic cells more efficiently than ruxolitinib - Experimental Hematology
Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell
